MEKanisms of a Serous Complication

JAMA Ophthalmol. 2017 May 1;135(5):413-414. doi: 10.1001/jamaophthalmol.2017.0275.

Authors

Cynthia L Montana¹, Rajendra S Apte²

Affiliations

¹ Department of Ophthalmology, Washington University School of Medicine, St Louis, Missouri.
² Department of Ophthalmology, Washington University School of Medicine, St Louis, Missouri2Department of Developmental Biology and Medicine, Washington University School of Medicine, St Louis, Missouri.

PMID: 28358947
DOI: 10.1001/jamaophthalmol.2017.0275

No abstract available

MeSH terms

Humans
MAP Kinase Kinase 1 / antagonists & inhibitors*
MAP Kinase Kinase 2 / antagonists & inhibitors*
Protein Kinase Inhibitors / adverse effects*
Retinal Detachment / chemically induced*
Retinal Detachment / diagnostic imaging*
Subretinal Fluid
Tomography, Optical Coherence

Substances

Protein Kinase Inhibitors
MAP2K2 protein, human
MAP Kinase Kinase 1
MAP Kinase Kinase 2
MAP2K1 protein, human